PL2934568T3

Dual glp1/gip or trigonal glp1/gip/glucagon agonists

Abstract

The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.

PL2934568T3, drawing sheet 1
Sheet 1 of 8

Term

7.2 yearsto projected expiry

Projected expiry 19 December 2033, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

8 sheets

  1. Sheet 1
  2. Sheet 2
  3. Sheet 3
  4. Sheet 4
  5. Sheet 5
  6. Sheet 6
  7. Sheet 7
  8. Sheet 8